MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SPEARS, C. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SPEARS, C. P.

Molecular Pharmacology, Vol 19, 496-504, Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics

Nucleophilic Selectivity Ratios of Model and Clinical Alkylating Agents by 4-(4'-Nitrobenzyl)pyridine Competition

C. PAUL SPEARS 1

1 Cancer Research Laboratories, University of Southern California Comprehensive Cancer Center, Los Angeles, California 90033

An aqueous acetone 4-(4'-nitrobenzyl)pyridine (NBP) assay for alkylating activity was used at neutral pH to reproduce the Swain-Scott-Ogston reactivity sequence of nucleophile n constants, based on bimolecular competition between NBP and added nucleophiles for alkylation by nitrogen mustards, methanesulfonate esters, methyl iodide, epichlorohydrin, or 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU). Nucleophile concentration-dependent decreases in the 540-nm NBP product(s) permitted determination of the second-order rate constant ratio, kx/knbp, for alkylation of the competing nucleophile/NBP. The slope, s*, of several log(kx/knbp) values versus n constants closely paralleled literature Swain-Scott s constants and could be derived from the value for thiosulfate competition, 1og(kss2oo3/knbp). Alkylating activity, defined by the maximal 540-nm absorbance found for reactions up to 1 hr, was clearly related to an alkylating agent’s nucleophilic sensitivity [s, s*, or log(kss2oo3/knbp) value]. Values of log(kSS2oo3/knbp) corresponding to s constants 0.78-1.39 for clinical alkylating agents increased in the order 1-chloroethyl-3-(4-methylcyclohexyl)-1-nitrosourea sim streptozotocin < 1,4-bis(methanesulfonoxy)butane sim BCNU < 1,1',l ''-phosphinothioylidynetrisaziridine sim methyl-bis(2-chloroethyl)amine < 4-[bis(2-chloroethyl)amino]-L-phenylalanine. NBP competition methods for determination of nucleophilic selectivity ratios should be highly useful for rapid identification of protective nucleophile-clinical alkylating agent combinations, and for classification of alkylating agent biological mechanism of action according to recent interpretations of alkylating agent kinetic behavior.

Note:
ACKNOWLEDGMENTS I am most grateful to Drs. Charles Heidelberger and George Olah for encouragement and helpful advice, and to Dr. Michael Colvin for his stimulating review of the manuscript. I am indebted to Margaret Soh for her patient typing.

Submitted on August 13, 1980
Accepted on December 3, 1980




This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
I. U. De Silva, P. J. McHugh, P. H. Clingen, and J. A. Hartley
Defining the Roles of Nucleotide Excision Repair and Recombination in the Repair of DNA Interstrand Cross-Links in Mammalian Cells
Mol. Cell. Biol., November 1, 2000; 20(21): 7980 - 7990.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
J. P.H. Wijen, M. J.M. Nivard, and E. W. Vogel
The in vivo genetic activity profile of the monofunctional nitrogen mustard 2-chloroethylamine differs drastically from its bifunctional counterpart mechlorethamine
Carcinogenesis, October 1, 2000; 21(10): 1859 - 1867.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics